Denise Braendgaard: How Partnership is Turning Ambition Into Action
Denise Braendgaard, General Manager at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared Novo Nordisk Haemophilia and Haemoglobinopathies Foundation‘s post on LinkedIn, adding:
“2025 was a year of transformation
At the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, we expanded our vision and scope, doubling down on our commitment to sustainable access to care for people living with haemophilia and haemoglobinopathies in low- and middle-income countries.
This progress was made possible by our partners: Their leadership, expertise, and dedication continue to drive sustainable, locally anchored impact.
Our Year in Review 2025 captures the milestones, the momentum, and the collective impact achieved together.
I invite you to take a moment to read it and see how partnership is turning ambition into action.”
Novo Nordisk Haemophilia and Haemoglobinopathies Foundation shared a post on LinkedIn:
“The NNHF Year in Review 2025 is here!
This year we focused on ‘Fostering connections and unveiling new horizons’, and the results speak for themselves.
Thanks to our partners, volunteers and funders, we reached new communities, launched meaningful initiatives, and expanded our impact.
Swipe through for some of the highlights, then read the Full Report for stories and outcomes that inspire.”
Other posts featuring Denise Braendgaard on Hemostasis Today.”
-
Oct 25, 2026, 18:36James P. Crowley: Gene Inactivation and Targeted Gene Repair as Two Approaches to CRISPR Gene Editing
-
Oct 25, 2026, 17:43Jan Sloves: Femoral Vein Aneurysm and Chronic Venous Obstruction
-
Oct 25, 2026, 17:31Kasimu Hussaini: Blood Component Therapy From Whole Blood to Targeted Treatment
-
Oct 25, 2026, 17:23Zahra Safarzadeh: When Low Factor VII Activity and Reduced VWF Antigen Coexist
-
Oct 25, 2026, 17:17Anubhav Joshi: Evans Syndrome in CLL A Differential Diagnosis to Remember
-
Oct 25, 2026, 17:04Tehila Alter: Tracking Hematopoietic Cell Engraftment in Bone Marrow Using CEST MRI
-
Oct 25, 2026, 16:45Shauna RileyÖ‰ First Guidelines for Hemoglobin SC Disease
-
Oct 25, 2026, 16:26Heghine Khachatryan: Patient Safety and Clinical Judgment in Platelet Transfusion Decisions
-
Oct 25, 2026, 16:13Funmi (Vanessa) Ullam: From Lived Experience to Research and Innovation in Sickle Cell Care